Glenmark appoints Dr Penelope Ward as president – clinical R&D & CMO

Glenmark appoints Dr Penelope Ward as president – clinical R&D & CMO
Glenmark Pharmaceuticals limited, a leading organization in the area of drug discovery, has appointed Dr Penelope(Penny) Ward as president – clinical research & development and chief medical officer. Dr Ward will be based at Glenmark’s clinical R&D centre in Oxford, United Kingdom.

Read more on PharmaBiz